Clinical trial
Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)
NCT00310856 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00310856 |
|---|---|
| Title | Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months) |
| Official title | A Phase 2, Partially Randomized, Open Label, Multicenter Study to Evaluate the Safety and Immunogenicity After One or Two Doses of Novartis (Formerly Chiron) Meningococcal ACWY Conjugate Vaccine Administered to Healthy Infants and Young Children |
| Lead sponsor | Novartis Vaccines, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Meningococcal Meningitis |
| Intervention type | Biological |
| Interventions | MenACWY-CRM, MenC-CRM, DTaP-Hib-IPV, PC7, MMR, Varicella |
| Enrollment | 175 |
| Start date | Jun 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Apr 5, 2006 |
| Last update posted | Oct 9, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: